Elsevier

Clinical Immunology

Volume 130, Issue 3, March 2009, Pages 290-297
Clinical Immunology

Enhanced expression of CCL20 in human Helicobacter pylori-associated gastritis

https://doi.org/10.1016/j.clim.2008.09.016Get rights and content

Abstract

CC chemokine ligand 20 (CCL20) attracts CC chemokine receptor 6 (CCR6)-expressing cells. Using endoscopic biopsies taken from the gastric antrum of 42 subjects infected with H. pylori and 42 uninfected subjects, mucosal CCL20 mRNA and protein levels were measured by real-time polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. CCL19 mRNA and protein levels, as well as CCL21 mRNA levels, were also measured. The CCL20 mRNA and protein levels were significantly elevated in H. pylori-positive patients and substantially decreased after successful eradication. CCL19 and CCL21 expression levels were comparable in the H. pylori-infected and the uninfected groups. The CCL20 concentrations correlated with the degree of chronic gastritis. Immunohistochemistry and the in vitro infection assay showed that CCL20 was principally produced by the gastric epithelium. CCR6-expressing cells, including CD45RO+ memory T lymphocytes and fascin+-CD1a+ immature dendritic cells, infiltrated close to the CCL20-expressing epithelial cells. The CCL20/CCR6 interaction may be involved in the development of H. pylori-associated gastritis.

Introduction

Helicobacter pylori is one of the most common infections in humans [1], [2]. This noninvasive organism colonizes the gastric epithelium and causes chronic gastritis that is characterized by dense infiltration of neutrophils and mononuclear cells into the lamina propria [3], [4]. H. pylori elicits specific antibodies against various immunogenic proteins derived from the bacterium [5]. Despite the cellular and humoral immune responses, H. pylori infection shows lifelong persistence in the majority of cases [1], [2]. The complex interplay between the bacterium and the host immune reaction is not fully understood.

Chemokines are a family of cytokines that are characterized by their biological ability to attract different cell types through their action on specific receptors, and they play a pivotal role in various immune and inflammatory conditions, including H. pylori-associated gastritis (HAG) [6], [7], [8], [9], [10], [11], [12]. We have previously demonstrated enhancement of mucosal production of interleukin 8 (IL-8), a representative chemoattractant for neutrophils, monocyte chemoattractant protein 1 (MCP-1), and regulated on activation normal T-cell expressed and presumably secreted (RANTES), both of which induce an influx of mononuclear cells, such as macrophages and lymphocytes, in patients with HAG [8]. Mucosal IL-8 concentrations have been associated with the degree of neutrophil infiltration, whereas the MCP-1 and RANTES levels have been shown to be correlated with the grades of mononuclear cell infiltration in H. pylori-infected gastric mucosa [8]. Accumulating evidence has shown that a variety of chemokines are involved in the development of HAG.

Dendritic cells (DCs) are dedicated antigen-presenting cells and function as central mediators between the innate and cognate immune systems [13]. DC trafficking is tightly controlled by differential expression of chemokine ligands and specific receptors; immature DCs that express CC-chemokine receptor 6 (CCR6) migrate towards its exclusive chemokine ligand, CC-chemokine ligand 20 (CCL20, also known as macrophage inflammatory protein 3α, liver and activation-regulated chemokines, or exodus-1) at the inflammatory site, where they capture and process antigens [14], [15]. Nishi et al. have reported that H. pylori infection upregulates CCL20 expression in gastric epithelial cells and induces an influx of DCs into the infected gastric mucosa of mice [10]. Recent studies have shown CCL20 upregulation and recruitment of CCR6-expressing CD3+ cells in gastric mucosa during H. pylori infection in humans [11], suggesting that CCL20 may play a role in HAG through interaction with the corresponding receptor.

The aim of the present study was to determine the role of CCL20 expression in the development of HAG in a relatively large number of subjects. The study was also designed to examine the expression of other lymphoid chemokines, CCL19 and CCL21, which are exclusive ligands for CCR7 expressed on mature type DCs [16], [17]. To determine whether H. pylori infection leads to CCL20 upregulation in vitro, CCL20 expression by gastric epithelial cells infected with diverse H. pylori strains was investigated.

Section snippets

Subjects and tissue samples

Consecutive outpatients who underwent upper gastrointestinal endoscopy for dyspepsia between June 2006 and May 2007 were recruited. The study was approved by the Nagasaki University Ethics Committee. All samples were obtained with the written informed consent of the patients prior to their inclusion, in accordance with the Helsinki Declaration. Exclusion criteria were: age < 18 or > 80 years, pregnancy, body mass index (BMI) > 30 kg/m2, diabetes mellitus, cachectic state (including cancer),

Baseline characteristics

A total of 84 patients (mean age: 64 years; range: 49–80 years), consisting of 58 men and 46 women, was studied. There were 32 current smokers and 37 alcohol drinkers. Based on the rapid urease test and histopathology, 42 subjects each were designated as either positive or negative for H. pylori infection. Baseline characteristics, including age, gender, alcohol intake, smoking habits, and body mass index, were not statistically different between the H. pylori-infected group and the uninfected

Discussion

The present results showed increased local production of CCL20, a representative lymphoid chemokine, in the gastric mucosa of patients infected with H. pylori. Nishi et al. were the first to report the association of H. pylori infection with CCL20 overexpression in murine gastric tissue [10]. Recent studies using RT-PCR showed that CCL20 mRNA expression was upregulated in H. pylori-infected gastric mucosa in humans, though only a small number of patients was examined [11], [12]. In the present

Acknowledgment

J Moss was supported by the intramural research program, NIH, NHLBI.

References (25)

  • H. Isomoto et al.

    Implication of NF-kappaB in Helicobacter pylori-associated gastritis

    Am. J. Gastroenterol.

    (2000)
  • M. Hansson et al.

    Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3beta) after exposure to Helicobacter pylori

    Microbes Infect.

    (2006)
  • M.J. Blaser et al.

    Helicobacter pylori persistence: biology and disease

    J. Clin. Invest.

    (2004)
  • P.B. Ernst et al.

    The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer

    Annu. Rev. Microbiol.

    (2000)
  • L.A.H. Allen

    The role of the neutrophils and phagocytosis in infection caused by Helicobacter pylori

    Curr. Opin. Infect. Dis.

    (2001)
  • T. Shimoyama et al.

    Bacterial factors and immune pathogenesis in Helicobacter pylori infection

    Gut

    (1998)
  • Y. Zevering et al.

    Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development

    Gut

    (1999)
  • M. Baggiolini

    Chemokines and leukocyte traffic

    Nature

    (1998)
  • A.D. Luster

    Chemokines—chemotactic cytokines that mediate inflammation

    N. Engl. J. Med.

    (1998)
  • M. Hansson et al.

    CCL28 is increased in human Helicobacter pylori-induced gastritis and mediates recruitment of gastric immunoglobulin A-secreting cells

    Infect. Immun.

    (2008)
  • T. Nishi et al.

    Involvement of myeloid dendritic cells in the development of gastric secondary lymphoid follicles in Helicobacter pylori-infected neonatally thymectomized BALB/c mice

    Infect. Immun.

    (2003)
  • Y.Y. Wu et al.

    Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis

    Infect. Immun.

    (2007)
  • Cited by (25)

    • A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer

      2019, EBioMedicine
      Citation Excerpt :

      Most of the 19 proteins are secreted. Apart from the clinically used biomarker CEACAM5, eight proteins have been reported for their clinical significances in both GC blood and tumour tissue, including MMP1 [29–31], MSLN [32–34], CA9 [35–37], CCL20 [38–40], SCF [41,42], TGF alpha [43–45], IGF-1 [46,47], and MMP10 [48]. The first four proteins were also found significantly increased in both GC serum and tumour tissue as analysed by univariate analysis in the present cohort, and SCF, TGF alpha, and MMP10 were significantly altered only in GC tissues, whereas IGF-1 were not changed in neither serum nor tissue.

    • Modulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis by Helicobacter pylori in immune pathogenesis of gastric mucosal damage

      2017, Journal of Microbiology, Immunology and Infection
      Citation Excerpt :

      CCR6, a specific β-chemokine receptor for CCL20, is selectively expressed on dendritic cells and some memory T cells,43,45,46 and may play a role in chemokine-mediated lymphocyte trafficking during gastric inflammation. Additionally, CCL20, the ligand of CCR6, is abundantly expressed in mouse and human inflammatory enteric mucosa,47 and CCL20 production was upregulated in response to H. pylori in gastric epithelial cells when there was stimulation by the proinflammatory cytokines IL-1β and TNF-α.14,48–50 These results implicated the interaction between CCL20 and CCR6 in recruiting CD45RO+ memory T cells to sites of inflammation in the gastric mucosa during Helicobacter infection (Figure 2).14

    View all citing articles on Scopus
    View full text